Doctor, Senior Engineer. I graduated from the Ocean University of China in 2015, and joined the Marine Biomedical Research Institute of Qingdao in the same year. Currently, I am the assistant dean. Mainly engaged in the research and development of marine carbohydrate drugs and functional products, especially focusing on the construction of marine carbohydrate engineering technology system, and solving the key problems of technology to engineering transformation. In recent years, the research work has mainly focused on the following aspects. In terms of sugar drug research and development, we have established an engineering technology system for marine sugar drugs and undertaken a series of sugar drug research and development. Among them, undertaking the development of the raw material preparation process for a new drug injection, seaweed beta glucan (code BG136), has been officially approved for clinical use on December 20, 2022, becoming the world's first immune anti-tumor marine candidate new drug.